Abstract

CHRONIC PAIN AFTER BREAST CANCER SURGERY OCcurs in approximately 50% of patients. The severity is variable, but sensory disturbances including paresthesias and phantom breast phenomena occur in approximately 47%. Potentially, this problem may increase with higher incidence of detected breast cancer and improved survival. Reasons for chronic discomfort after surgery are varied and complex, but nerve damage associated with axillary lymph node dissection is the most commonly reported cause and is associated with a doubling in prevalence compared with cases without this procedure. Interactions among treatment modalities such as type of breast surgery, axillary procedures, adjuvant chemotherapy, and radiation therapy add to the difficulty involved in the overall evaluation. In this issue of JAMA, Gartner and colleagues report findings from a cross-sectional study from Denmark that evaluated women undergoing an operation for unilateral primary breast cancer and documented the prevalence, location, severity, and frequency of persistent pain and sensory disturbances in 12 well-defined treatment groups. More than 3000 women completed questionnaires that addressed issues of specific regions of symptoms, severity of pain, frequency of symptoms, physician visits due to pain in the operated region, use of analgesics or other treatment for pain in the operated region, and pain in other locations. The responses were also analyzed with regard to age of the patient and treatment modalities for the breast cancer. The results are compelling. Almost half (47%) of the respondents reported pain in one or more areas, and 52% of those patients rated the discomfort as severe or moderate. As many as 76% of patients with severe pain experienced discomfort on a daily basis. The breast area was the most frequently reported site of pain, followed by the axilla, the arm, and the side of the body, and 40% experienced pain in other nonsurgical areas. The use of analgesics was relatively prevalent; other modalities for relief of pain such as physiotherapy and massage were also used. Predictive factors most significantly associated with chronic pain included young age (18-39 years), especially if the patient was treated with breast-conserving surgery. Treatment with adjuvant radiation therapy, but not chemotherapy, increased the risk for development of pain. Mastectomy carried a higher risk for moderate and severe distress compared with breast-conserving surgery. Axillary node dissection was more often associated with frequency of pain as well as severity of pain than sentinel node biopsy, regardless of the type of surgery to the breast. Patients with complaints of pain in other areas of the body were more likely to develop increased pain in the surgical site (65%) compared with women without pain in nonsurgical sites (37%). Sensory disturbance was more frequently reported by younger patients. The likelihood for development of any sensory discomfort was highest for patients treated with breastconserving surgery, axillary lymph node dissection, and chemotherapy with breast radiation therapy or breast and localregional radiation therapy. Of patients who reported sensory disturbances, 65% also experienced a type of pain suggesting that sensory abnormalities and nerve injury may lead to increased pain risk. Comparisons with other studies examining this issue may be difficult due to inconsistencies in definitions of chronic pain, different measurements of pain, studies from single institutions, changes in mix of surgical techniques and adjuvant treatment over time, and variable intervals in assessment of pain after surgery. Insufficient numbers of patients may also limit conclusions. An advantage of the study by Gartner et al is the large number of patients, 3253 nationwide, compared with other studies with 85 to 1600 patients. The larger population provides better risk estimates for all treatment modalities. Also, treatment principles are standardized at all breast cancer treatment facilities in Denmark according to European guidelines and national

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call